Status: Ongoing, but not recruiting participants
ClinicalTrials.gov Identifier: NCT02251938
Santen 32-009: A Phase IIIB, Multi-National, Multi-Center, Open-Label Extension Study Assessing the long-term Safety of the PRN Intravitreal Injections of DE-109 in subjects with Non-Infectious Uveitis of the Posterior Segment of the Eye who have participated in the SAKURA Development program.
Condition: Non-Infectious Uveitis of the Posterior Segment of the Eye
Study Type: Interventional
Duration: 12 months
For additional information on this study, please click hereBack to Clinical Research